Astellas Overactive Bladder Drug Raises Risks, FDA Says

Astellas Pharma Inc.’s drug to treat overactive bladder has side effects including increased blood pressure that need to be considered when weighing whether the medicine should be approved, U.S. regulators said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.